Fundraising FoxBill & Melinda Gates Foundation — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Pula is an investment and advisory firm that operates an accelerator program in partnership with Nigeria's Sovereign Investment Authority, supporting early-stage ventures in climate resilience, agricultural technology, insurance technology, and regulatory technology across African markets.
AgTechClimate TechInsurTechNairobi, ZA
Thomas Njeru(Co-Founder and CEO)inRose Goslinga(Co-Founder and President)in
Co-investorsAccionInternational Finance CorporationMulago FoundationTLcom Capital
Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.
BiotechFemTechHealthtech
Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)
Co-investorsAngelini VenturesIndaco Venture PartnersOMX VenturesSofinnova Partners
Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity.
AI & Machine LearningBiotechHealthtechSeattle, US
Ivan Liachko(Founder)inShawn Sullivan(Executive Officer, Promoter)in
Co-investorsAlliance of AngelsCongruent VenturesHemi Ventures, Llc
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Toronto Innovation Acceleration PartnersAmplitude Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.